Items Tagged ‘News Tips and Features Other’


OMNI Health Media is a leading online provider of Daily Health News. OMNI’s News Tips And Features Other News provides summaries of developments in the prevention, screening, and management of Gastrointestinal Health Conditions as they are discovered and reported by physicians and scientists around the world. Our mission is to provide this news, including results of recent clinical trials evaluating new therapies and supportive care strategies in order to better educate patients and their caregivers, ensuring timely access to the best care available.
Inflammatory Bowel Disease is Associated with Increased risk of other Immune Mediated Diseases

October 17th, 2017

Inflammatory Bowel Disease is Associated with Increased risk of other Immune Mediated Diseases

By cancerconnect cancerconnect

A Danish National Patient Registry based analyses has shown higher rates of immune mediated diseases (IMD) in patients with inflammatory bowel disease (IBD). Inflammatory Bowel Disease is an immune-mediated chronic inflammation of the gastrointestinal tract. Normally, the cells and proteins that make up the immune system protect you from infection. In people with IBD, however, […]

View full entry

Tags: ankylosing spondylitis, Asthma, Celiac Disease, immune mediated disease, Inflammatory Bowel Disease, Iridocyclitis, News Tips and Features, News Tips and Features Other, Primary sclerosing cholangitis, psoriasis, Pyoderma gangrenosum, rheumatoid arthritis


Flu Shot 101 – What You Need to Know

October 17th, 2017

Flu Shot 101 – What You Need to Know

By cancerconnect cancerconnect

Flu season is here again, and besides a fever and runny nose, it can bring about the longtime controversy surrounding vaccines. In order to protect more human lives this year and to clarify some of the most common misconceptions surrounding the flu vaccine, the team at ConsumerSafety.org met with Dr. William Schaffner, an infectious disease […]

View full entry

Tags: flu vaccine, Influenza, News Tips and Features, News Tips and Features Other


Ask the Expert: Focus on Ankylosing Spondylitis

October 16th, 2017

Ask the Expert: Focus on Ankylosing Spondylitis

By megm megm

The SpineCommunity Presents: Ask the Expert with Dr. David Borenstein David G. Borenstein, MD recently answered your questions on ankylosing spondylitis (AS) in TheSpineCommunity.  TheSpineCommunity is an online support community for individuals affected with conditions of the spine, join the conversation here. Question: What are the best exercises for ankylosing spondylitis? Dr. Borenstein:  The difficulty […]

View full entry

Tags: ankylosing spondylitis, AS, crohn's, crohn's disease, crohns disease ulcerative colitis, crohn’s ulcerative colitis, Exercise, IL17 inhibitors, iritis, neuropathy, News Tips and Features, News Tips and Features Other


October 16th, 2017

Targeting both BRAF and EGFR doubles progression-free survival in metastatic colorectal cancer

By Anonymous User anonymous_user_10987

Recent successes in genetically targeted precision cancer medicines are improving outcomes in a number of cancers.  Ensuring patients undergo genomic sequencing to determine if they have treatable targets is increasingly important to ensure patients receive the most appropriate personalized care. Precision cancer medicine utilizes molecular diagnostic testing, including DNA sequencing, to identify cancer-driving abnormalities in […]

View full entry

Tags: BRAF, Colon Cancer, erbitux, News Tips and Features, News Tips and Features Other, Precision Cancer Medicine, Rectal Cancer, V600E, vemurafenib, Zelboraf


New Standard of Care for Treatment of Resectable Gastric Cancer

October 3rd, 2017

New Standard of Care for Treatment of Resectable Gastric Cancer

By Anonymous User anonymous_user_10987

The superiority of docetaxel based triplet therapy over standard care in patients with resectable esophago-gastric cancer has been confirmed in late-breaking results from the FLOT4 trial presented at the ESMO 2017 Congress in Madrid.1 Survival in resectable esophago-gastric cancer is poor. Five-year overall survival is around 25% with surgery, and is increased to 36% by […]

View full entry

Tags: Esophageal Cancer, esophago-gastric cancer, Gastric Cancer, News Tips and Features, News Tips and Features Other


The US Food and Drug Administration has Expanded the Approval of the Precision Cancer Medicine Keytruda for Treatment of Gastric Cancer

September 25th, 2017

The US Food and Drug Administration has Expanded the Approval of the Precision Cancer Medicine Keytruda for Treatment of Gastric Cancer

By Anonymous User anonymous_user_10987

Keytruda (Pembrolizumab) is now indicated for patients with recurrent locally advanced or metastatic gastric or gastro-esophogeal junction adenocarcinoma. Patients eligible for keytruda therapy under this new indication must have PD-L1-expressing tumors, and must demonstrate disease progression after two or more prior lines of therapy – including fluoropyrimidine- and platinum-containing chemotherapy and, in some cases, HER2/neu-targeted […]

View full entry

Tags: checkpoint inhibitor, Esophageal Cancer, Gastric Cancer, gastro-esophogeal junction cancer, keytruda, metastatic gastric, News Tips and Features, News Tips and Features Other, pembrolizumab, Precision Cancer Medicine


NSAIDs Decrease Risk of Colorectal Cancer

September 18th, 2017

NSAIDs Decrease Risk of Colorectal Cancer

By Anonymous User anonymous_user_10987

Nonsteroidal anti-inflammatory drugs (NSAIDS) are medicines that are used for the treatment of a wide range of musculoskeletal illnesses including spinal disorders, osteoarthritis and inflammatory conditions like rheumatoid arthritis. NSAIDs effectively relieve pain, inflammation, and fever.  A number of treatment guidelines for osteoarthritis, rheumatoid arthritis, and chronic low back pain recommend the use of NSAIDs […]

View full entry

Tags: Colon Cancer, News Tips and Features, News Tips and Features Other, Rectal Cancer


Keytruda Immunotherapy Appears Promising in Advanced Gastric Cancer

September 18th, 2017

Keytruda Immunotherapy Appears Promising in Advanced Gastric Cancer

By Anonymous User anonymous_user_10987

Keytruda (pembrolizumab) appears promising in patients with pretreated metastatic gastric cancer, according to late-breaking results from the KEYNOTE-059 trial presented at the European Society for Medical Oncology (ESMO) 2017 Congress in Madrid.1 Stomach cancer (gastric cancer), is the third leading cause of cancer-related deaths worldwide. Overall, the 5-year survival rate for patients with gastric cancer […]

View full entry

Tags: Gastric Cancer, immunotherapy, KEYNOTE-059 programmed death-ligand 1, keytruda, metastatic gastric cancer, News Tips and Features, News Tips and Features Other, PD-L1, pembrolizumab, Precision Cancer Medicine, stomach cancer


CONDITIONS OF THE GI TRACT